Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Worldwide Shipping!
Find out more »
CD200R1 encodes a receptor for the OX-2 membrane glycoprotein. Additionally we are shipping CD200R1 Proteins (22) and CD200R1 Kits (12) and many more products for this protein.
Showing 10 out of 280 products:
Human Polyclonal CD200R1 Primary Antibody for WB - ABIN611279 : Basu, Dong, Krainer, Howe: The intracisternal A-particle proximal enhancer-binding protein activates transcription and is identical to the RNA- and DNA-binding protein p54nrb/NonO. in Molecular and cellular biology 1997 (PubMed) Show all 3 Pubmed References
Mouse (Murine) Monoclonal CD200R1 Primary Antibody for FACS - ABIN2479156 : Ueda: Normal volume of the thyroid gland in children. in Journal of clinical ultrasound : JCU 1990 (PubMed) Show all 4 Pubmed References
Mouse (Murine) Monoclonal CD200R1 Primary Antibody for FACS - ABIN2479154 : Wright, Cherwinski, Foster-Cuevas, Brooke, Puklavec, Bigler, Song, Jenmalm, Gorman, McClanahan, Liu, Brown, Sedgwick, Phillips, Barclay: Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. in Journal of immunology (Baltimore, Md. : 1950) 2003 (PubMed) Show all 4 Pubmed References
Mouse (Murine) Monoclonal CD200R1 Primary Antibody for FACS - ABIN2479166 : Zhao, Zhao, Van Rooijen, Perlman: Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. in PLoS pathogens 2009 (PubMed) Show all 4 Pubmed References
Mouse (Murine) Monoclonal CD200R1 Primary Antibody for FACS - ABIN2479165 : Björck, Leong, Engleman: Plasmacytoid dendritic cell dichotomy: identification of IFN-? producing cells as a phenotypically and functionally distinct subset. in Journal of immunology (Baltimore, Md. : 1950) 2011 (PubMed) Show all 4 Pubmed References
Mouse (Murine) Polyclonal CD200R1 Primary Antibody for CyTOF, FACS - ABIN4899957 : Stumpfova, Ratner, Desciak, Eliezri, Owens: The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma. in Cancer research 2010 (PubMed) Show all 2 Pubmed References
Rat (Rattus) Monoclonal CD200R1 Primary Antibody for FACS - ABIN2479138 : Mechanic: The orginization of medical practice and practice orientations among physicians in prepaid and nonprepaid primary care settings. in Medical care 1975 (PubMed) Show all 3 Pubmed References
we demonstrated for the first time that CD200R is highly expressed on cells involved in type 2 immune responses, namely on Th2, Tc2 (show TCN2 Antibodies), ILC2, and basophils. All these cell types play a role in type 2 inflammation.
Residual CD200 (show CD200 Antibodies) activity may prevent completion of abortions via induction of Treg cells. In chronic histiocytic intervillositis, infiltrating maternal effector T cells may block Treg induction. An autocrine role for CD200 (show CD200 Antibodies)-CD200R interaction versus inhibition of soluble CD200 (show CD200 Antibodies) by soluble CD200R is discussed.
MMP12 (show MMP12 Antibodies)-producing monocyte-derived cells in gingival tissue of periodontitis patients also had reduced CD200R surface levels. Treatment with a CD200R ligand reduced CSF2 (show CSF2 Antibodies)-induced MMP12 (show MMP12 Antibodies) production in these cells. This novel association of the CD200 (show CD200 Antibodies)/CD200R pathway with MMP12 (show MMP12 Antibodies) production by monocyte-derived cells may play a key role in PD progression.
Coexpression of CD200R-CD28 enhances function in WT1-spec (show CD28 Antibodies)ific T-cell receptor - transduced (show CD8A Antibodies) human primary T cells.
Our findings suggest a promising role of CD200R as a prognostic marker in predicting elevated recurrence and reduced survival, and a potential therapeutic target in treating hepatocellular carcinoma.
we revealed a critical role for CD200R signaling in limiting the growth and metastasis of CD200 (show CD200 Antibodies)(+) tumors.
Constitutively expressed Siglec-9 (show SIGLEC9 Antibodies) inhibits LPS (show IRF6 Antibodies)-induced CCR7 (show CCR7 Antibodies), but enhances IL-4 (show IL4 Antibodies)-induced CD200R expression in human macrophages.
Inflammatory Bowel Disease patients showed a significant decrease in the percentage of plasmacytoid dendritic cells and myeloid dendritic cells expressing CD200R1 compared to that of the control group.
CD200 (show CD200 Antibodies)-CD200R1 signaling may be required for human pregnancy success.
This is the first report of CD200R1 expression by human epithelial tumor cells, and specifically, early-stage human breast cancer cells. It is also the first report of CD200R1 expression by term placental villous trophoblasts.
In adoptive therapy of disseminated leukemia, CD200R-CD28 (show CD28 Antibodies)-transduced leukemia-specific CD8 (show CD8A Antibodies) T cells eradicated otherwise lethal disease more efficiently than wild-type cells and bypassed the requirement for interleukin-2 (show IL2 Antibodies) administration to sustain in vivo activity.
CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization.
Data show that neutrophil infiltration of tissues was markedly decreased in CD200 antigen (show CD200 Antibodies) (tg) transgenic animals and increased in CD200 receptor 1 CD200R1(-/-) knockout mice.
we show a causal role for the CD200 (show CD200 Antibodies)-CD200R inhibitory axis in arteriogenesis in a murine hindlimb ischemia model.
CD200 (show CD200 Antibodies)-CD200R1 interaction in glial cells is involved in the neuroprotective action of PPAR-gamma (show PPARG Antibodies) agonists.
[review] Influenza-infected CD200R1-deficient mice show less bacterial load and exhibit decreased pathogenesis and mortality than wild-type animals following streptococcal pneumonia superinfection.
Anti-CD200R2 (show CD200R1L Antibodies), anti-IL-9 (show IL9 Antibodies), anti-IL-35, or anti-TGF-beta (show TGFB1 Antibodies) abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice, and suggest combined role of mast cells and Tregs.
AML1 (show RUNX1 Antibodies)-ETO (show RUNX1T1 Antibodies) upregulated CD200R1 in lineage(-) cells, which was characteristic of AML1 (show RUNX1 Antibodies)-ETO (show RUNX1T1 Antibodies)-positive leukemia in mice.
a role for both graft and host CD200 (show CD200 Antibodies)/CD200R expression in increased allograft survival.
This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. Mouse studies of a related gene suggest that this interaction may control myeloid function in a tissue-specific manner. Alternative splicing of this gene results in multiple transcript variants.
CD200 cell surface glycoprotein receptor , MOX2 receptor , cell surface glycoprotein CD200 receptor 1 , cell surface glycoprotein OX2 receptor 1 , cell surface glycoprotein receptor CD200 , OX102 antigen , OX2 receptor , antigen identified by monoclonal antibody MRC OX-2 receptor , CD200 receptor 1 , CD200 cell surface glycoprotein receptor 1-A , CD200 receptor 1 A , cell surface glycoprotein CD200 receptor 1-A , cell surface glycoprotein OX2 receptor 1-A , Orexin receptor 2